(VIANEWS) – New Mountain Finance Corporation (NMFC), Medpace Holdings (MEDP), Fidus Investment Corporation (FDUS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. New Mountain Finance Corporation (NMFC)
27.5% sales growth and 7.56% return on equity
New Mountain Finance Corporation (Nasdaq: NMFC), a business development company is a private equity / buyouts and loan fund specializes in directly investing and lending to middle market companies in “defensive growth” industries. The fund prefers investing in buyout and middle market companies. It also makes investments in debt securities at all levels of the capital structure including first and second lien debt, unsecured notes, and mezzanine securities. In some cases, its investments may also include equity interests. It targets energy, engineering and consulting services, specialty chemicals and materials, trading companies and distributors, commercial printing, diversified support services, education services, environmental and facilities services, office services and supplies, media, distributors, health care services, health care facilities, application software, business services, systems software, federal services, distribution and logistics, interactive home entertainment, telecommunication services, hydroelectric power generation, electric power generation by fossil fuels, electric power generation by nuclear fuels, health care technology, and security and alarm services. The fund seeks to invest in United States of America. It seeks to invest between $10 million and $125 million per transaction. The firm invests through both primary originations and open-market secondary purchases. It invests in companies with EBITDA between $10 million and $200 million. The fund seeks a majority stake in its portfolio companies.
Earnings Per Share
As for profitability, New Mountain Finance Corporation has a trailing twelve months EPS of $0.95.
PE Ratio
New Mountain Finance Corporation has a trailing twelve months price to earnings ratio of 13.41. Meaning, the purchaser of the share is investing $13.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.56%.
Moving Average
New Mountain Finance Corporation’s worth is above its 50-day moving average of $12.68 and higher than its 200-day moving average of $12.44.
Earnings Before Interest, Taxes, Depreciation, and Amortization
New Mountain Finance Corporation’s EBITDA is 27.52.
Volume
Today’s last reported volume for New Mountain Finance Corporation is 280511 which is 17.22% below its average volume of 338877.
2. Medpace Holdings (MEDP)
25.4% sales growth and 79.68% return on equity
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Earnings Per Share
As for profitability, Medpace Holdings has a trailing twelve months EPS of $8.54.
PE Ratio
Medpace Holdings has a trailing twelve months price to earnings ratio of 31.74. Meaning, the purchaser of the share is investing $31.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 79.68%.
Moving Average
Medpace Holdings’s value is higher than its 50-day moving average of $248.47 and way higher than its 200-day moving average of $217.66.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 0.5% and positive 1.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 31.2%, now sitting on 1.67B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Medpace Holdings’s EBITDA is 5.04.
3. Fidus Investment Corporation (FDUS)
14.5% sales growth and 8.8% return on equity
Fidus Investment Corporation is a business development company. It specializing in leveraged buyouts, refinancings, change of ownership transactions, recapitalizations, strategic acquisitions, mezzanine, growth capital, business expansion, lower middle market investments, debt investments, subordinated and second lien loans, senior secured and unitranche debt, preferred equity, warrants, subordinated debt, senior subordinated notes, junior secured loans, and unitranche loans. It does not invest in turnarounds or distressed situations. The fund prefers to invest in aerospace and defense, business services, consumer products and services including retail, food, and beverage, healthcare products and services, industrial products and services, information technology services, niche manufacturing, transportation and logistics, and value-added distribution sectors. It seeks to invest in companies based in United States. The fund typically invests between $5 million and $15 million per transaction in companies with annual revenues between $10 million and $150 million and an annual EBITDA between $3 million and $20 million, but it can occasionally invest in larger or smaller companies. It seeks to acquire minority equity stakes and board observation rights in conjunction with its investments.
Earnings Per Share
As for profitability, Fidus Investment Corporation has a trailing twelve months EPS of $1.72.
PE Ratio
Fidus Investment Corporation has a trailing twelve months price to earnings ratio of 11.14. Meaning, the purchaser of the share is investing $11.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.8%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Fidus Investment Corporation’s EBITDA is 10.07.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 18, 2023, the estimated forward annual dividend rate is 2.29 and the estimated forward annual dividend yield is 11.95%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 21.6% and 17.6%, respectively.
Sales Growth
Fidus Investment Corporation’s sales growth is 24.3% for the ongoing quarter and 14.5% for the next.
4. Meta Platforms (META)
12.6% sales growth and 17.36% return on equity
Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. Meta Platforms, Inc. was incorporated in 2004 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Meta Platforms has a trailing twelve months EPS of $8.86.
PE Ratio
Meta Platforms has a trailing twelve months price to earnings ratio of 33.99. Meaning, the purchaser of the share is investing $33.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.36%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 105.5% and 155.7%, respectively.
Previous days news about Meta Platforms(META)
- According to Zacks on Tuesday, 12 September, "Snapchat, being a leader in the AR advertising market, is experiencing a stiff competition from giants like Amazon (AMZN Quick QuoteAMZN – Free Report) , Meta Platforms (META Quick QuoteMETA – Free Report) and Google (GOOGL Quick QuoteGOOGL – Free Report) ."
- According to Zacks on Thursday, 14 September, "For the Tech sector, you can see this favorable revisions trend in estimates for operators like Meta Platforms (META Quick QuoteMETA – Free Report) , Alphabet (GOOGL Quick QuoteGOOGL – Free Report) , Nvidia (NVDA Quick QuoteNVDA – Free Report) and others."
- According to MarketWatch on Thursday, 14 September, "These individuals should possess technical knowledge, but also a keen understanding of the social impact of AI." Warner offered advice a day after members of the Senate met with tech executives from Microsoft Corp. , Alphabet Inc.’s Google, Facebook parent Meta Platforms Inc. , Nvidia Corp. , and Tesla Inc. to discuss the promise and peril of AI."
5. Hyster (HY)
10.9% sales growth and 14.09% return on equity
Hyster-Yale Materials Handling, Inc., through its subsidiaries, designs, engineers, manufactures, sells, and services a line of lift trucks, attachments, and aftermarket parts worldwide. It manufactures components, such as frames, masts, and transmissions; and assembles lift trucks. The company markets its products primarily under the Hyster and Yale brand names to independent Hyster and Yale retail dealerships. It also sells aftermarket parts under the Hyster and Yale, as well as UNISOURCE and PREMIER brands to Hyster and Yale dealers for the service of competitor lift trucks. In addition, the company produces and distributes attachments, forks, and lift tables under the Bolzoni, Auramo, and Meyer brand names; and designs and produces products in the port equipment and rough terrain forklift markets. Further, it designs, manufactures, and sells hydrogen fuel-cell stacks and engines. The company serves light and heavy manufacturers, trucking and automotive companies, rental companies, building materials and paper suppliers, lumber, metal products, warehouses, retailers, food distributors, container handling companies, and U.S. and non-U.S. governmental agencies. Hyster-Yale Materials Handling, Inc. was incorporated in 1991 and is headquartered in Cleveland, Ohio.
Earnings Per Share
As for profitability, Hyster has a trailing twelve months EPS of $2.01.
PE Ratio
Hyster has a trailing twelve months price to earnings ratio of 22.96. Meaning, the purchaser of the share is investing $22.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.09%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 21.8%, now sitting on 3.92B for the twelve trailing months.
6. McCormick & Company (MKC)
8.5% sales growth and 14.62% return on equity
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry. It operates in two segments, Consumer and Flavor Solutions. The Consumer segment offers spices, herbs, and seasonings, as well as condiments and sauces, and desserts. This segment markets its products under the McCormick, French's, Frank's RedHot, Lawry's, Cholula Hot Sauce, Gourmet Garden, Club House, and OLD BAY brands in the Americas; Ducros, Schwartz, Kamis, and LA Drogheria, and Vahiné brands in Europe, the Middle East, and Africa; McCormick and DaQiao brands in China; and McCormick, Aeroplane, and Gourmet Garden brands in Australia, as well as markets regional and ethnic brands, such as Zatarain's, Stubb's, Thai Kitchen, and Simply Asia. It also supplies its products under the private labels. This segment serves retailers comprising grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce retailers directly and indirectly through distributors and wholesale foodservice suppliers. The Flavor Solutions segment offers seasoning blends, spices and herbs, condiments, coating systems, and compound flavors to multinational food manufacturers and foodservice customers. It serves foodservice customers directly and indirectly through distributors. McCormick & Company, Incorporated was founded in 1889 and is headquartered in Hunt Valley, Maryland.
Earnings Per Share
As for profitability, McCormick & Company has a trailing twelve months EPS of $2.59.
PE Ratio
McCormick & Company has a trailing twelve months price to earnings ratio of 30.89. Meaning, the purchaser of the share is investing $30.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.62%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 6, 2023, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 1.93%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
McCormick & Company’s EBITDA is 4.08.
Previous days news about McCormick & Company(MKC)
- According to Zacks on Thursday, 14 September, "We have highlighted three better-ranked stocks, namely MGP Ingredients, Inc. (MGPI Quick QuoteMGPI – Free Report) , McCormick & Company (MKC Quick QuoteMKC – Free Report) and Celsius Holdings (CELH Quick QuoteCELH – Free Report) .MGP Ingredients produces and markets ingredients and distillery products to the packaged goods industry. "
- According to Zacks on Tuesday, 12 September, "We have highlighted two better-ranked stocks, namely MGP Ingredients, Inc. (MGPI Quick QuoteMGPI – Free Report) and McCormick & Company (MKC Quick QuoteMKC – Free Report) .MGP Ingredients produces and markets ingredients and distillery products to the packaged goods industry. "
7. Option Care Health (OPCH)
7.2% sales growth and 17.39% return on equity
Intuitive Surgical (ISRG Quick QuoteISRG – Free Report) and Option Care Health (OPCH Quick QuoteOPCH – Free Report) are a couple of top-ranked stocks that investors can consider in the broader sector., Long-term earnings growth rates for Intuitive Surgical and Option Care Health are pegged at 15.7% and 20.24%, respectively.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.33.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 26.28. Meaning, the purchaser of the share is investing $26.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.39%.
